Impact of the Glasgow prognostic score on prognosis in patients with community-acquired pneumonia

被引:0
|
作者
Eraslan, Berrin Zinnet [1 ]
Icmeli, Ozlem Saniye [1 ]
Havan, Ayse [1 ]
Demirer, Ersin [1 ]
Comert, Sevda Sener [1 ]
机构
[1] Univ Hlth Sci, Kartal Dr Lutfi Kirdar City Hosp, Dept Chest Dis, Istanbul, Turkiye
关键词
CAP; community-acquired pneumonia; glasgow prognostic score; GPS; mortality; prognosis; SERUM-ALBUMIN; MORTALITY; SEVERITY; ADULTS;
D O I
10.14744/ejp.2024.38128
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BACKGROUND AND AIM: Pneumonia is one of the leading causes of morbidity and mortality worldwide. This study aimed to evaluate the impact of the Glasgow prognostic score (GPS) on the prognosis of patients hospitalized with community-acquired pneumonia (CAP). METHODS: A retrospective review was conducted on patients hospitalized in our department with CAP. The GPS was calculated based on C-reactive protein (CRP) and albumin levels. RESULTS: The study included 121 patients, of whom 80 (66.1%) were male. The median age was 70 years. Early mortality occurred in 11 patients (9.1%). Patients with a GPS of 2 had significantly longer hospital stays than those with a GPS <= 1 (p=0.002). Similarly, early mortality rates were statistically significantly higher in patients with a GPS of 2 (17.3%) compared to those with a GPS <= 1 (2.9%) (p=0.009). A receiver operating characteristic (ROC) curve analysis was performed to determine the cutoff point for predicting mortality using the GPS. GPS values of 1.5 or higher were found to predict mortality with a sensitivity of 81.82% and a specificity of 60.91%. Age, average length of hospital stay, and the incidence of malignancy were significantly higher in patients who died within 30 days compared to survivors (p=0.011, p=0.001, and p=0.041, respectively). Upon evaluating the effects of age, length of hospital stay, GPS, and malignancy-which were found to be significant in univariate analyses-using logistic regression analysis, GPS was not identified as having a significant impact on mortality. CONCLUSIONS: The GPS is associated with early mortality in patients with CAP. However, its independent impact on mortality is not statistically significant when considering other factors such as age, length of hospital stay, and malignancy. This suggests that while GPS can be a useful indicator for initial assessments, its prognostic value may be limited when other clinical variables are considered.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [1] Prognostic factors in patients hospitalized with community-acquired aspiration pneumonia
    Seo, Hyewon
    Cha, Seung-Ick
    Lee, Won Kee
    Park, Ji-Eun
    Choi, Sun Ha
    Lee, Yong-Hoon
    Yoo, Seung-Soo
    Lee, Shin-Yup
    Lee, Jaehee
    Kim, Chang-Ho
    Park, Jae-Yong
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (01) : 47 - 53
  • [2] How to assess survival prognosis in patients hospitalized for community-acquired pneumonia in 2024?
    Ramirez, Julio A.
    File, Thomas M.
    CURRENT OPINION IN CRITICAL CARE, 2024, 30 (05) : 399 - 405
  • [3] Prediction of prognosis by markers in community-acquired pneumonia
    Viasus, Diego
    Simonetti, Antonella
    Garcia-Vidal, Carolina
    Carratala, Jordi
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (09) : 917 - 929
  • [4] Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia
    Lee, Jae Hyuk
    Kim, Jooyeong
    Kim, Kyuseok
    Jo, You Hwan
    Rhee, JoongEui
    Kim, Tae Youn
    Na, Sang Hoon
    Hwang, Seung Sik
    JOURNAL OF CRITICAL CARE, 2011, 26 (03) : 287 - 294
  • [5] Serial procalcitonin levels for predicting prognosis in community-acquired pneumonia
    Ito, Akihiro
    Ishida, Tadashi
    Tachibana, Hiromasa
    Ito, Yuhei
    Takaiwa, Takuya
    RESPIROLOGY, 2016, 21 (08) : 1459 - 1464
  • [6] Community-acquired pneumonia as an emergency condition
    Cilloniz, Catia
    Dominedo, Cristina
    Garcia-Vidal, Carolina
    Torres, Antoni
    CURRENT OPINION IN CRITICAL CARE, 2018, 24 (06) : 531 - 539
  • [7] Prognosis of hospitalized patients with community-acquired pneumonia
    Akyil, F. Tokgoz
    Yalcinsoy, M.
    Hazar, A.
    Cilli, A.
    Celenk, B.
    Kilic, O.
    Sayiner, A.
    Kokturk, N.
    Coskun, A. Sakar
    Filiz, A.
    Edis, E. Cakir
    PULMONOLOGY, 2018, 24 (03): : 164 - 169
  • [8] Validation of the qSOFA score compared to the CRB-65 score for risk prediction in community-acquired pneumonia
    Kesselmeier, Miriam
    Pletz, Mathias W.
    Blankenstein, Anna Leona
    Scherag, Andre
    Bauer, Torsten
    Ewig, Santiago
    Kolditz, Martin
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (09) : 1345.e1 - 1345.e6
  • [9] Multimarker Prognostication for Hospitalized Patients with Community-acquired Pneumonia
    Lee, So Yeon
    Cha, Seung-Ick
    Seo, Hyewon
    Oh, Serim
    Choi, Keum-Ju
    Yoo, Seung-Soo
    Lee, Jaehee
    Lee, Shin-Yup
    Kim, Chang-Ho
    Park, Jae-Yong
    INTERNAL MEDICINE, 2016, 55 (08) : 887 - 893
  • [10] Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort
    Ito, Akihiro
    Ishida, Tadashi
    Tokumasu, Hironobu
    Washio, Yasuyoshi
    Yamazaki, Akio
    Ito, Yuhei
    Tachibana, Hiromasa
    BMC PULMONARY MEDICINE, 2017, 17